Orexin receptor 2 agonist improves sleepiness in narcolepsy
For patients with narcolepsy type 1, an orexin receptor 2 agonist, TAK-994, improves measures of sleepiness and cataplexy over eight weeks compared with placebo but is associated with hepatotoxic adverse events, according ...
Jul 27, 2023
0
11